HMP Global (a leading omnichannel healthcare events and education company) recently announced that the International Myeloma Foundation (IMF) is a partner for the 2023 Lymphoma, Leukemia & Myeloma Congress (LL&M)—the premier forum for industry-leading hematologic research and clinical case studies.

The 2023 LL&M Congress will take place from October 18-21 at the Sheraton New York Times Square Hotel in New York City. "LL&M is the meeting where interdisciplinary specialists convene to explore the controversial and complex world of blood cancer through debate, discussion, and networking. The educational program covers emerging data, innovative treatment methods, and emerging trends in lymphoma, myeloma, and leukemia disorders," states HMP Global's press release.

“It is critical that like-minded organizations like IMF and LL&M work together to educate clinicians and develop strategies that improve patient care and outcomes. Together, we are advancing the science and research that will improve our patients’ lives while we work toward prevention and finding a cure,” said IMF Chief Medical Officer Dr. Joseph Mikhael.

To know more about the 2023 LL&M Congress, read the full press release.